Integrated clinical–genetic–pathological analysis expands the phenotypic and molecular spectrum of PPNAD across carney complex and isolated forms
European Journal of Endocrinology · 03.08.2026 · 195 (2) · 217-228
DOI: 10.1093/ejendo/lvag137 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Endocrinology, online erschienen am 03.08.2026. Verfasst von Aliny Weber Kuhn und 13 weiteren Autor:innen. Beteiligte Einrichtung: Adrenal Unit, Clinicas Hospital, Discipline of Endocrinology and Metabolism, School of Medicine, University of Sao Paulo, Sao Paulo 05403-000, Brazil. Hauptthemen laut MEDLINE: Carney Complex, Adrenal Cortex Diseases. Die Arbeit nennt 41 Literaturangaben. Gefördert von: São Paulo Research Foundation (FAPESP), FAPESP fellowship.
Abstract (Originalsprache)
Context
Primary pigmented nodular adrenocortical disease (PPNAD) is a rare cause of ACTH-independent Cushing syndrome (CS), occurring in isolation or as part of Carney complex (CNC); its phenotypic and molecular spectra remain incompletely defined.
Objective
To characterize phenotypic variability, genotype–phenotype correlations, and molecular findings in PPNAD through integrated clinical, histopathological, and genetic analyses.
Methods
We evaluated 18 index patients with PPNAD (15 with CNC, 3 isolated) and performed cascade genetic screening in relatives (20 variants-positive). Clinical, hormonal, imaging and histopathological data were reviewed; germline and somatic analyses employed targeted next-generation sequencing and copy-number assessment.
Results
Overt CS was present in 83% of index cases; 17% had cyclic hypercortisolism. Pathogenic or likely-pathogenic germline PRKAR1A variants were identified in 70.6% probands, including four novel variants; germline PRKACA duplications were detected in two cases. Cascade screening identified eight asymptomatic variant-positive relatives, in whom mild autonomous cortisol secretion (MACS) was observed. Somatic second-hit alterations in tumor tissue included PRKACA duplication, a PRKAR1A frameshift deletion, and 17q24.2 loss of heterozygosity. Histology most often showed classic PPNAD but also nonclassical patterns, expanding the morphological spectrum. Extra-adrenal manifestations were frequent (lentigines 61%, cardiac myxomas 22%).
Conclusion
In this referral cohort, PPNAD/CNC displays marked phenotypic variability, incomplete penetrance with subclinical cortisol excess, and diverse molecular mechanisms, including novel germline variants and somatic second hits. Some cases lacked identifiable drivers, suggesting additional uncharacterized mechanisms. Systematic genetic screening and recognition of MACS are important for early diagnosis and long-term management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Adrenal Unit, Clinicas Hospital, Discipline of Endocrinology and Metabolism, School of Medicine, University of Sao Paulo, Sao Paulo 05403-000, Brazil.
- Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48105, United States.
- Genomic and Signaling of Endocrine Tumors Team, INSERM U1016, CNRS UMR8104, Cochin Institute, Paris Cité University, Paris 75005, France.
- Department of Endocrinology, Diabetes and Nutrition, Rennes University Hospital, Rennes 35000, France.
- Hormones and Molecular Genetics Laboratory LIM/42, SELA Laboratory, Clinicas Hospital, Discipline of Endocrinology and Metabolism, School of Medicine, University of Sao Paulo, Sao Paulo 05403-000, Brazil.
- Division of Anatomic Pathology, Clinicas Hospital, School of Medicine, University of Sao Paulo, Sao Paulo 01246-903, Brazil.
ORCID-Profile: Aliny Weber Kuhn, Antonio Marcondes Lerario, Helaine Laiz Charchar, Beatriz Marinho de Paula Mariani, Patricia Vaduva, Mirian Yumie Nishi, Felipe Lourenco Ledesma, Victor Srougi, Berenice B Mendonca, Ana Claudia Latronico, Jérôme Bertherat, Madson Q Almeida, Maria Candida Barisson Villares Fragoso
Förderung
- São Paulo Research Foundation (FAPESP)
- FAPESP fellowship
Zitieren
APA
Kuhn, A. W., Lerario, A. M., Charchar, H. L., Mariani, B. M. P., Vaduva, P., Nishi, M. Y., Ledesma, F. L., Srougi, V., Chambô, J. L., Mendonca, B. B., Latronico, A. C., Bertherat, J., Almeida, M. Q., & Fragoso, M. C. B. V. (2026). Integrated clinical–genetic–pathological analysis expands the phenotypic and molecular spectrum of PPNAD across carney complex and isolated forms. European Journal of Endocrinology, 195(2), 217-228. https://doi.org/10.1093/ejendo/lvag137
Vancouver
Kuhn AW, Lerario AM, Charchar HL, Mariani BMP, Vaduva P, Nishi MY, et al. Integrated clinical–genetic–pathological analysis expands the phenotypic and molecular spectrum of PPNAD across carney complex and isolated forms. European Journal of Endocrinology. 2026;195(2):217-228. doi:10.1093/ejendo/lvag137
BibTeX
@article{Kuhn2026,
author = {Kuhn, Aliny Weber and Lerario, Antonio Marcondes and Charchar, Helaine Laiz and Mariani, Beatriz Marinho de Paula and Vaduva, Patricia and Nishi, Mirian Yumie and Ledesma, Felipe Lourenco and Srougi, Victor and Chambô, José Luis and Mendonca, Berenice B and Latronico, Ana Claudia and Bertherat, Jérôme and Almeida, Madson Q and Fragoso, Maria Candida Barisson Villares},
title = {Integrated clinical–genetic–pathological analysis expands the phenotypic and molecular spectrum of PPNAD across carney complex and isolated forms},
journal = {European Journal of Endocrinology},
year = {2026},
volume = {195},
number = {2},
pages = {217--228},
doi = {10.1093/ejendo/lvag137}
}
EUVIMED